SLNO•prnewswire•
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses
Summary
SAN DIEGO, Dec. 15, 2025 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether Soleno Therapeutics, Inc. (NASDAQ: SLNO) or certain of its officers and directors violated federal securities laws by making false or misleading statements and/or failing to...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 16, 2025 by prnewswire